# Treatment for Chronic Pain in Patients With Advanced Cancer

> **NCT00003687** · PHASE3 · COMPLETED · sponsor: **NCIC Clinical Trials Group** · enrollment: 87 (actual)

## Conditions studied

- Chronic Myeloproliferative Disorders
- Leukemia
- Lymphoma
- Multiple Myeloma and Plasma Cell Neoplasm
- Myelodysplastic Syndromes
- Pain
- Precancerous/Nonmalignant Condition
- Small Intestine Cancer
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** dextromethorphan hydrobromide
- **DRUG:** morphine sulfate

## Key facts

- **NCT ID:** NCT00003687
- **Lead sponsor:** NCIC Clinical Trials Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-06-11
- **Primary completion:** 2001-09-26
- **Final completion:** 2009-02-10
- **Target enrollment:** 87 (ACTUAL)
- **Last updated:** 2020-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003687, "Treatment for Chronic Pain in Patients With Advanced Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00003687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*